News

May 2011

GlaxoSmithKline's patient assistance programs provide access to prescription medicines to eligible low income uninsured patients.

In 2010,

  • GSK's patient assistance programs provided access to over 450,000 patients,
  • Patients received approximately 2.9 million 30-day prescription fills,
  • The value of the products provided to patients was over $612 million (Wholesale Acquisition Cost).

Every day, product valued over $1.7M (Wholesale Acquisition Cost) was provided to patients by our programs.

This website is funded and developed by GlaxoSmithKline.
This site is intended for US healthcare professionals only.
© 1997-2012 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Contact Us